Zogenix Reports Granting of Inducement Award Under Nasdaq

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Zogenix Reports Granting of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Dec. 20, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq: ZGNX ), a pharmaceutical company developing and commercializing products for the treatment of central nervous system disorders and pain, reported today that it has issued an inducement award to Bradley S. Galer, M.D., the company's newly appointed Executive Vice President and Chief Medical Officer.

The award was made on December 17, 2013 under Zogenix's Employment Inducement Equity Incentive Award Plan, which provides for the granting of equity awards to new employees of Zogenix as an inducement to join the company. The inducement award consists of options to purchase an aggregate of 425,000 shares of Zogenix common stock. The options have a ten-year term and an exercise price equal to $3.02, the fair market value of Zogenix common stock on the date of grant. The options vest over a four-year period, with 25% of the options vesting on the first anniversary of the date of grant and the remainder vesting in equal monthly installments over the three years thereafter. The awards were approved by the independent compensation committee of Zogenix's board of directors and were granted as an inducement material to Dr. Galer entering into employment with Zogenix in accordance with Nasdaq Marketplace Rule 5635(c)(4).

About Zogenix

Zogenix, Inc. (Nasdaq: ZGNX ), with offices in San Diego and Emeryville, California, is a pharmaceutical company committed to developing and commercializing therapies that address specific clinical needs for people living with central nervous system disorders and pain-related conditions who need innovative treatment alternatives to help them return to normal daily functioning. Zogenix recently received FDA approval for Zohydro ER TM (hydrocodone bitartrate) extended-release capsules, the first extended-release oral formulation of hydrocodone without acetaminophen. Zogenix developed and commercialized the first needle-free subcutaneous injection, SUMAVEL ® DosePro ® (sumatriptan injection) for migraine and cluster headache. The development pipeline for Zogenix includes a once-monthly subcutaneous injection for schizophrenia.

SUMAVEL ® , DosePro ® and Zohydro TM ER are trademarks of Zogenix, Inc.

FPR

Investors Zack Kubow | The Ruth Group 646.536.7020 | Media Amy Wheeler | The Ruth Group 646.536.7025 |

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JJ Lin's Iconic Singapore Grand Prix Show With 20 Songs

Updated Category News Views 2

Nothing beats the thrill of a live performance under a night sky, with the adrenaline of a Formula 1 race still in the air. On October 9, 2026, Mandopop superstar JJ Lin captivated the crowd at the Padang Stage of the Singapore Grand Prix, delivering not just a concert but a spectacle of international scale. Stage Spectacle with Precision JJ Lin took control like a...

Continue Reading
BP Resolves Deepwater Horizon Matters with Louisiana

Updated Category News Views 2

Pay Upfront, Clean Up Later Well, finally. BP's tossed a $350 million olive branch at Louisiana, closing the book on those dragging Deepwater Horizon economic damage payments. It’s that classic payout shuffle up another seven years packed into a lump sum, letting the state grab their share now rather than stretching it out like a lousy old gum. A Step Towards a Fresh...

Continue Reading
Scage Future's ADS Ratio Change: What's Next?

Updated Category News Views 4

A New Era for Scage Future's ADS Holders You don't wake up every day to catch a one-for-fifteen reverse ADS split staring you right in the face, but for Scage Future's shareholders, that's exactly what's happening. The company, a pretty big deal in the zero-emission heavy-duty vehicle scene, made waves by announcing they're tinkering with their ADS ratio. You see, the...

Continue Reading
Supercar Buying: Key Factors to Verify First

Updated Category News Views 3

The Grind of Securing a Limited-Edition Supercar If you're grinding to buy one of those elusive limited-edition supercars, you'd better buckle up. According to Kendall Gath over at iLusso, this ain't like picking up groceries at the local market. There's a whole list of things to consider before you even think about handing over your wad of cash. Differentiating Fact from...

Continue Reading
Rich McLaughlin Takes Helm of WFUV Radio

Updated Category News Views 3

A Familiar Face Steers the Ship at WFUV There's something about returning to your roots that often feels like coming home. For Rich McLaughlin, taking over as general manager of WFUV is like slipping into a well-worn pair of shoes. He's known the rhythms and quirks of this place since his college days at Fordham, and now he's at the helm, guiding this beloved New York...

Continue Reading
Hexagon Composites to Release Q3 2026 Results Soon

Updated Category News Views 3

Anticipating Hexagon's Third Quarter 2026 Results Hexagon Composites ASA, based out of Oslo, Norway, is setting the stage to release its third quarter 2026 financial results. Mark your calendars for November 6, 2026, at the early bird hour of 07:00 am CET. For those of us keen on dissecting the numbers, that's when the real action begins. Executive Insights Await A...

Continue Reading
Mahomes Faces Pressure to Ditch AIRSHARE After Tragedy

Updated Category News Views 0

Patrick Mahomes and the AIRSHARE Dilemma When the air turns turbulent, even the lucky stars often tremble. Kansas City Chiefs’ star quarterback, Patrick Mahomes, finds himself smack in the eye of such a storm. With a name as illustrious as his, the links to AIRSHARE, a private jet provider caught in the crosshairs of tragedy, create more than just a PR hiccup—they...

Continue Reading
Symplr's Strategic Refinancing: A Shot in the Arm

Updated Category News Views 5

Symplr's Financial Revamp: What It Means You're not often floored by a refinancing move, but symplr's announcement on October 23 sure seems like a savvy maneuver. For a company that's already a lynchpin in healthcare operations, extending debt maturities and juicing up liquidity is like an adrenaline shot to the ticker. And for me, it's the confidence from heavyweights...

Continue Reading
Data Center Cooling Market to Hit $1B by 2033

Updated Category News Views 5

The Heat's On: Immersion Cooling Fluid Market Booms Kicking off with numbers straight out of the gate, data center immersion cooling fluids are gearing up for a wild ride. From just $0.23 billion back in 2026, this market is on a blitz to hit a whopping $1.06 billion by 2033. We're talking a hefty 24.8% compound annual growth rate. That's no small shakes. Race for Energy...

Continue Reading
Hi3D Unlocks AI 3D Model for Open-Source Innovation

Updated Category News Views 4

A New Era in 3D Model Accessibility Unless you’ve been hiding under a rock, it’s hard to miss how digital terraforming has shifted gears. With Hi3D V1.0 opening its doors, the playing field's getting a major reshuffle. Or, as they say, the table is being set, and everyone's getting a seat. By letting loose production-validated AI tools, Hi3D is throwing down the...

Continue Reading

Top 5 Most Recently Viewed Articles

Aberdeen International Strengthens Leadership Team with New CFO

Updated Category News Views 270

Leadership Changes at Aberdeen International Aberdeen International Inc. (TSX: AAB, OTC: AABVF) has exciting news for its stakeholders as the company announces the appointment of Stephen Woodhead as the new Chief Financial Officer. This strategic decision comes at a pivotal time for the company, enhancing its financial leadership and positioning for future growth. Stephen...

Continue Reading
Gyre Therapeutics to Showcase Advancements at Major Conference

Updated Category News Views 178

Gyre Therapeutics to Present at the H.C. Wainwright Conference Gyre Therapeutics, a leading biotechnology firm, is poised to make a significant appearance at the upcoming H.C. Wainwright MASH Investor Conference. The event, which is an important gathering for investors and industry leaders, will take place shortly. About Gyre Therapeutics Gyre Therapeutics is a...

Continue Reading
Linden Creek Launches New Franchise to Enhance Design Experience

Updated Category News Views 221

Linden Creek Expands to Enhance Interior Design Services Linden Creek, a distinguished luxury interior design and home staging firm, has taken a significant step by launching its latest franchise location in Jacksonville, Florida. This new endeavor exemplifies the company’s commitment to broadening its impact in the southeastern United States and making high-quality...

Continue Reading
Nxera Pharma Partners with Shionogi to Advance QUVIVIQ™ in Japan

Updated Category News Views 193

Nxera Pharma struck gold back in late 2024 when they inked a deal with Shionogi to push their sleep disorder treatment, QUVIVIQ™, into the Japanese market. This ain't just another partnership; it's about positioning QUVIVIQ™ as a heavyweight contender among dual orexin antagonists, specifically aimed at knocking out insomnia. The previous arrangement with Mochida...

Continue Reading
The Rise of Ad-Supported Streaming Services for Consumers

Updated Category News Views 302

Understanding the Shift Towards Ad-Supported Streaming Ad-supported streaming services are increasingly capturing the attention of consumers as they carefully re-evaluate their entertainment budgets. With more viewers weighing the costs and benefits of subscription models, many are turning to services that integrate advertising rather than paying for ad-free experiences....

Continue Reading